<html>
<head>PUBMED IDs for SEC61G</head>
<body bgcolor='#C5F0F2'><h1>SEC61G</h1><a href='https://pubmed.ncbi.nlm.nih.gov/12883658/'>Identification and characterization of human ZPBP-like gene in silico.</a> July 29  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/16739104/'>EGFR amplification and lack of activating mutations in metaplastic breast carcinomas.</a> June 2  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/18798223/'>Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer.</a> September 18  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19276369/'>Functional genomic analysis identified epidermal growth factor receptor activation as the most common genetic event in oral squamous cell carcinoma.</a> May 14  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/23263746/'>Natural HLA class I ligands from glioblastoma: extending the options for immunotherapy.</a> September 12  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24871463/'>GWAS identifies novel SLE susceptibility genes and explains the association of the HLA region.</a> June 24  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25725245/'>Balkan nephropathy.</a> May 25  2015<br></body></html>
